Literature DB >> 8444884

Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-gamma and -alpha. Analysis of the regulatory region of the gene and identification of an interferon-gamma-inducible DNA-binding factor.

H H Hassanain1, S Y Chon, S L Gupta.   

Abstract

The induction of indoleamine 2,3-dioxygenase (IDO) activity has been implicated in the antiproliferative action of interferon (IFN)-gamma on tumor cells and the inhibition of intracellular pathogens. Earlier studies have demonstrated that the expression of the IDO gene is induced strongly by IFN-gamma, but very poorly by IFN-alpha despite the presence of a sequence highly homologous to the IFN-alpha-responsive sequence element (interferon-stimulated response element (ISRE)) in its IFN-gamma-responsive control region. In addition, a sequence with a partial homology to the IFN-gamma-responsive sequence (GAS) identified by Lew et al. (Lew, D.J., Decker, T., Strehlow, I., and Darnell, J.E., Jr. (1991) Mol. Cell. Biol. 11, 182-191) in a human gene for a guanylate-binding protein and to the X box sequence found in all major histocompatibility complex class II genes was found. Deletion experiments have indicated that the ISRE homolog (but not the GAS-related or the X box-related sequence) was essential for an inducibility by IFN-gamma. To investigate the lack of inducibility by IFN-alpha despite the presence of an ISRE homolog, the binding of this ISRE homolog to the IFN-alpha-stimulated gene factor 3 (ISGF3) was examined. Gel mobility shift experiments and competition experiments indicated that this ISRE homolog did not form a stable complex with ISGF3. This may account for a poor inducibility by IFN-alpha. This inability to bind ISGF3 appears to be (at least in part) due to minor differences between the nucleotide sequence of the ISRE homolog present in the IDO gene promoter and the ISRE consensus sequence found in IFN-alpha-inducible genes. An IFN-gamma-inducible DNA-binding factor was identified with characteristics different from ISGF3: (i) the IFN-gamma-inducible factor was detected in the nuclear extracts, but not in the cytoplasmic extracts; and (ii) the appearance of this DNA-binding factor required new protein synthesis, which could explain the dependence on new protein synthesis for the induction of IDO by IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8444884

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  IFN-γ-driven IDO production from macrophages protects IL-4Rα-deficient mice against lethality during Schistosoma mansoni infection.

Authors:  Reena Rani; Michael B Jordan; Senad Divanovic; De'Broski R Herbert
Journal:  Am J Pathol       Date:  2012-03-16       Impact factor: 4.307

Review 2.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

Authors:  Tracy L McGaha; Lei Huang; Henrique Lemos; Richard Metz; Mario Mautino; George C Prendergast; Andrew L Mellor
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

3.  Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection.

Authors:  Jennifer A Loughman; David A Hunstad
Journal:  J Infect Dis       Date:  2012-04-03       Impact factor: 5.226

4.  Tolerogenic interactions between CD8+ dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts.

Authors:  David Hongo; Xiaobin Tang; Xiangyue Zhang; Edgar G Engleman; Samuel Strober
Journal:  Blood       Date:  2017-01-17       Impact factor: 22.113

Review 5.  The kynurenine system and immunoregulation.

Authors:  Yvette Mándi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-07-09       Impact factor: 3.575

6.  Positive T cell co-stimulation by TLR7/8 ligands is dependent on the cellular environment.

Authors:  Denise Richardt-Pargmann; Miriam Wechsler; Arthur M Krieg; Jörg Vollmer; Marion Jurk
Journal:  Immunobiology       Date:  2010-04-09       Impact factor: 3.144

7.  HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase activity.

Authors:  Grant J Logan; Christine M F Smyth; John W Earl; Irina Zaikina; Peter B Rowe; Jason A Smythe; Ian E Alexander
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

8.  Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase.

Authors:  Alberto Molano; Petr A Illarionov; Gurdyal S Besra; Chaim Putterman; Steven A Porcelli
Journal:  Immunol Lett       Date:  2008-01-28       Impact factor: 3.685

9.  LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia.

Authors:  Yunxia Wang; Marcus A Lawson; Robert Dantzer; Keith W Kelley
Journal:  Brain Behav Immun       Date:  2009-07-03       Impact factor: 7.217

10.  In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1.

Authors:  Ian M Zitron; David O Kamson; Sam Kiousis; Csaba Juhász; Sandeep Mittal
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.